Elsevier, a leading publisher of scientific, technical and medical information products and services, announced today, that its journal Vaccine, the most comprehensive and pre-eminent journal for those interested in vaccines and vaccination, will organize the 3rd Vaccine Global Congress from 4-6 October, 2009, in Singapore. For people who cannot attend the congress in Singapore, Elsevier is organizing a Vaccine Virtual counterpart. This truly interactive event will allow people to sample the high-quality content and networking opportunities that the congress and exhibition provide from their desk.
Following the successful Second Vaccine Congress held in Boston last year, the meeting in Singapore will again serve as an authoritative international interface between academics in research and development, regulatory and governmental agencies, charities, and health and industry professionals.
The 3rd Vaccine Global Congress is organized in collaboration with the International Society for Vaccines (http://www.isv-online.org/). At the congress, both GSK and Novartis will present their latest data on H1N1 flu vaccine research. To supplement a number of invited keynote speakers, multiple oral and poster presentations have been selected to cover all facets of vaccinology, including: human vaccines for infectious and non-infectious diseases, veterinary vaccines, adjuvants, drug delivery, production, safety and regulatory aspects.